Joint Committee on Pharmaceutical Excipients

  • 1.  PE-2022-1 Section 7.1.3.1 - 363i15.docx uploaded

    Posted 03-13-2024 09:28 AM
    Document Name: PE-2022-1 Section 7.1.3.1 - 363i15.docx
    No description provided.
    Download Latest Revision
    Public Download Link
    Submitter: Rachel Brooker
    Group: Joint Committee on Pharmaceutical Excipients
    Folder: 06/XX/24
    Date submitted: 2024-03-13 13:28:10


    ---------------------------------
    Rachel Brooker Standards Development Liaison
    Standards Development Liaison
    NSF
    734-827-6866 Standards Development Liaison
    rbrooker@nsf.org
    ---------------------------------


  • 2.  RE: PE-2022-1 Section 7.1.3.1 - 363i15.docx uploaded

    Posted 03-14-2024 10:57 AM

    Hello Everyone

    Although I have retired from working with the excipient manufacturer and distributor, Croda, I am still working for EXCiPACT and am a co-opted member of IPEC Europe (amongst other "pastimes").

    I'd still like to help with this standard, bring my expertise in standard writing and excipients to help the team. Rachel has indicated I can have Observer status.

     

    Given the recent issue of the new edition of the IPEC-PQG GMP Guide do we need to do a complete review of ANSI NSF 363 as it stands to align with the new edition of the IPEC-PQG GMP Guide?

    regards

     

    Dr. Iain Moore

    GMP Risk Assessment Consulting

    +44 7455 166707

     




    Original Message


  • 3.  RE: PE-2022-1 Section 7.1.3.1 - 363i15.docx uploaded

    Posted 03-14-2024 02:16 PM

    The ballot you sent says choose all applicable dates/times, but it only allows us to select 1. 

     




    Original Message


  • 4.  RE: PE-2022-1 Section 7.1.3.1 - 363i15.docx uploaded

    Posted 2 days ago
    I am sorry,I think it is too late to vote on the revision of
    PE-2022-1 Section 7.1.3.1 - 363i15.docx .
    I have undergone ear surgery ans was not reachable by e-mail.I can vote now,I think it is too late.I am in favor of the proposed Change.
    Best regards
    Anne Gayot

    Professor Anne Gayot
    mobile:
    06 82 22 26 51



    De: "Rachel Brooker via NSF Standards" <Mail@nsf.org>
    À: "Anne Gayot" <anne.gayot@univ-lille.fr>
    Envoyé: Mercredi 13 Mars 2024 14:28:17
    Objet: Joint Committee on Pharmaceutical Excipients : PE-2022-1 Section 7.1.3.1 - 363i15.docx uploaded

    Document Name: PE-2022-1 Section 7.1.3.1 - 363i15.docx No description provided. Download Latest Revision ... -posted to the "Joint Committee on Pharmaceutical Excipients" community



    Original Message


Related Content